2m 2m 2m 2m 2m 2m 2m
RANI THERAP-A (RANI)
NASDAQ
$0.86-$0.02 (-2.30%)
Price as of Jun 03, 2026 7:44 PM EDT- $106.9MMarket Cap
- 56.30%1-Year Change
- BiotechnologyIndustry
RANI THERAP-A (RANI)
$0.86-$0.02 (-2.30%)
RANI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.88 | ||
Change | +$0.02 (+2.03%) | ||
Open | $0.86 | ||
High | $0.88 | ||
Low | $0.83 | ||
Previous Close | $0.86 | ||
Volume | 718,498 | ||
30-Day Average Volume | 1,180,596 | ||
1-Week Change | -7.88% | ||
1-Month Change | -6.90% | ||
1-Year Change | 56.30% | ||
3-Year Change | -80.47% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 112.4M | ||
Total Assets | $51.9M | ||
Market Cap | $106.9M | ||
Enterprise Value | $97.2M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$7.0M | ||
Free Cash Flow | -$6.5M | ||
EBIT | -$6.9M | ||
EBITDA | -$6.8M | ||
Net Working Capital | $33.2M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 57 | ||
P/B | 4 | ||
P/E | -24 | ||
PEG | 0 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue